We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Personality Characteristics and Compliance With Antiglaucoma Medication (GDC)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified May 2007 by Yonsei University.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT00481494
First Posted: June 1, 2007
Last Update Posted: June 1, 2007
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Yonsei University
May 31, 2007
June 1, 2007
June 1, 2007
May 2007
Not Provided
Not Provided
Not Provided
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Personality Characteristics and Compliance With Antiglaucoma Medication
Personality Characteristics and Compliance With Antiglaucoma Medication
Personality traits may influence to the drug compliance in glaucoma patients.
In chronic diseases, especially asymptomatic at early stage, drug compliance has been reported as an important factor to control them. And personality traits are associated with the drug compliance. However, there was few study to consider this relationship. We want to find the association the personality characteristics and drug compliance in glaucoma patients.
Observational
Time Perspective: Cross-Sectional
Time Perspective: Prospective
Not Provided
Not Provided
Not Provided
Not Provided
Glaucoma
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Unknown status
150
October 2007
Not Provided

Inclusion Criteria:

  • Chronic glaucoma
  • Topical anti-glaucoma medications

Exclusion Criteria:

  • Oral glaucoma medications
Sexes Eligible for Study: All
20 Years to 80 Years   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Korea, Republic of
 
 
NCT00481494
4-2007-0092
No
Not Provided
Not Provided
Not Provided
Yonsei University
Not Provided
Study Chair: Chan Yun Kim, MD, PhD Department of Ophthalmology, Yonsei University College of Medicine
Yonsei University
May 2007